Arrowhead Pharmaceuticals Inc (ARWR)

Exchange
NASDAQ
Symbol
ARWR
Sector
Healthcare
Industry
Biotechnology
Description
Arrowhead Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm headquartered in Pasadena, California, pioneering the use of its proprietary RNA interference (RNAi) technology to develop transformative therapies for challenging diseases, particularly liver disorders and genetic conditions. With a robust pipeline of drug candidates and a commitment to innovative gene silencing and targeted therapeutics, Arrowhead is at the forefront of addressing significant unmet medical needs. The company's strategic partnerships enhance its capabilities, positioning it to advance a range of candidates through clinical trials and potentially reshape treatment paradigms in the biopharmaceutical landscape.
Country
USA

Stock price

At close: December 31, 2025

  • Open
    66.51
  • High
    67.26
  • Low
    66.00
  • Close
    66.39
  • Volume
    1,066,510

Financial ratios

Sep 30, 2025